Total Payments
$294.19
2022 Payments
$50.78
Companies
11
Transactions
17
Medicare Patients
10,583
Medicare Billing
$904,250
Payment Breakdown by Category
Food & Beverage$277.94 (94.5%)
Education$16.25 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $277.94 | 16 | 94.5% |
| Education | $16.25 | 1 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $67.10 | 4 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $50.78 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $35.38 | 2 | $0 (2019) |
| PFIZER INC. | $31.29 | 2 | $0 (2018) |
| Allergan Inc. | $23.17 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $23.06 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $13.36 | 1 | $0 (2019) |
| AbbVie Inc. | $13.33 | 1 | $0 (2021) |
| Novo Nordisk Inc | $13.32 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $11.84 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $50.78 | 1 | E.R. Squibb & Sons, L.L.C. ($50.78) |
| 2021 | $26.65 | 2 | AbbVie Inc. ($13.33) |
| 2019 | $76.96 | 5 | Janssen Pharmaceuticals, Inc ($41.31) |
| 2018 | $79.11 | 6 | PFIZER INC. ($31.29) |
| 2017 | $60.69 | 3 | Janssen Pharmaceuticals, Inc ($25.79) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/01/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $50.78 | General |
| Category: Oncology | ||||||
| 08/24/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes | ||||||
| 09/05/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $16.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/14/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: UROLOGY | ||||||
| 04/03/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/23/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/26/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $11.56 | General |
| 05/15/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/24/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/28/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: RESPIRATORY | ||||||
| 03/23/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,975 | 3,938 | $457,972 | $193,782 |
| 2022 | 24 | 2,584 | 4,618 | $499,566 | $218,483 |
| 2021 | 24 | 3,267 | 5,523 | $542,196 | $259,030 |
| 2020 | 25 | 2,757 | 5,305 | $532,911 | $232,955 |
Total Patients
10,583
Total Services
19,384
Medicare Billing
$904,250
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 371 | 667 | $127,397 | $55,918 | 43.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 457 | 997 | $133,598 | $55,134 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 249 | 333 | $88,578 | $36,694 | 41.4% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 52 | 119 | $15,470 | $9,700 | 62.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 229 | 229 | $27,480 | $9,170 | 33.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 87 | 516 | $18,060 | $8,520 | 47.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 15 | $4,605 | $2,506 | 54.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 58 | 576 | $4,032 | $2,419 | 60.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 46 | 51 | $4,335 | $2,152 | 49.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $1,990 | $1,910 | 96.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 56 | 56 | $1,960 | $1,875 | 95.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 44 | 46 | $3,864 | $1,873 | 48.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $5,814 | $1,641 | 28.2% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 72 | 72 | $10,800 | $1,489 | 13.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 31 | $1,550 | $1,021 | 65.9% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 72 | 72 | $5,400 | $732.96 | 13.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 63 | 65 | $1,950 | $672.60 | 34.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 11 | $1,089 | $354.28 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 508 | 1,052 | $140,970 | $61,566 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 419 | 704 | $134,464 | $56,015 | 41.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 204 | 262 | $69,692 | $30,845 | 44.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 271 | 271 | $32,925 | $10,690 | 32.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 83 | 563 | $19,705 | $9,090 | 46.1% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2022 | 45 | 99 | $12,870 | $8,155 | 63.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 187 | 187 | $5,610 | $5,498 | 98.0% |
About Dr. Matthew Blundell, MD
Dr. Matthew Blundell, MD is a Internal Medicine healthcare provider based in Crescent City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073511796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Blundell, MD has received a total of $294.19 in payments from pharmaceutical and medical device companies, with $50.78 received in 2022. These payments were reported across 17 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($277.94).
As a Medicare-enrolled provider, Blundell has provided services to 10,583 Medicare beneficiaries, totaling 19,384 services with total Medicare billing of $904,250. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Crescent City, CA
- Active Since 07/07/2005
- Last Updated 09/13/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073511796
Products in Payments
- XARELTO (Drug) $53.87
- OPDIVO (Biological) $50.78
- ENTRESTO (Drug) $35.38
- VIBERZI (Drug) $23.17
- ANORO (Drug) $23.06
- CHANTIX (Drug) $17.08
- LYRICA (Drug) $14.21
- MYRBETRIQ (Drug) $13.36
- VRAYLAR (Drug) $13.33
- Ozempic (Drug) $13.32
- INVOKANA (Drug) $13.23
- ASMANEX (Drug) $11.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Crescent City
Dr. Moustafa Eldick, M.d, M.D
Internal Medicine — Payments: $6,571
Internal Medicine $6,571
Dr. Vicki Gordon, Md Phd, MD PHD
Internal Medicine — Payments: $148.98
Internal Medicine $148.98
Jocelyn Talbot, Md, MD
Internal Medicine — Payments: $14.41
Internal Medicine $14.41
Nkiruka Ndu, M.d, M.D
Internal Medicine — Payments: $14.03
Internal Medicine $14.03
Donald Micheletti, Md, MD
Internal Medicine
Internal Medicine
Albena Dimitrova, Md, MD
Internal Medicine
Internal Medicine